Intragastric Balloon (BIB System) in the Treatment of Obesity and Preparation of Patients for Surgery - Own Experience and Literature Review

• Authors: Stanisław Dąbrowiecki , Wojciech Szczęsny , Cezary Popławski , Dariusz Sosnowski
• Languages of publication: EN

Abstracts

EN

Despite the recognition of bariatric surgery as the only effective method of weight reduction, we remain in search of minimally invasive methods, both for the treatment of obesity and preparation of patients for surgical procedures.The aim of the study was to determine intragastric balloon (Allergan) implantation results as the only method of treating obesity, and patient preparation for further stages of abdominal hernia operations, as well as other surgical procedures.Material and methods. The study presented own results considering the use of Bioenteric Intragastric Balloons (BIB system) in the treatment of pathological obesity, and preparation of patients for bariatric surgery and abdominal hernia operations. The study group comprised 18 female and 7 male patients. Average patient age amounted to 50.6 and 54 years, respectively. Indications for intragastric balloon insertion were as follows: preparation for hernia (10 cases) and bariatric (5 patients) operations, and weight reduction management (8 patients). In two cases the implantation of the intragastric balloon served the preparation for gynecological and orthopedic (vertebral column) operations. One female patient was prepared for both bariatric and hernial surgery. The procedure was performed under general anesthesia. Statistical analysis considered 22 patients (one female patient was excluded from analysis, due to death, two other were excluded because of lack of sufficient data).Results. In case of two patients the intragastric balloon system was removed before 6 months had elapsed because of intolerance. One female patient died during the observation period for reasons not related to the procedure. The obtained BMI reduction ranged between 2 and 6 kg/m2, which amounted to a maximum weight loss of 24 kg. In one patient a weight gain of 2 kg was observed. Considering patients prepared for abdominal hernia operations weight reduction was greater and better maintained after the removal of the BIB system.Conclusions. According to the authors of the presented study the intragastric balloon serves its role as a bridge to bariatric procedures and weight reduction, before planned extensive postoperative hernia operations. The use of the intragastric balloon only to reduce weight has no medical and economic justification.

Keywords

EN

intragastric balloon; preparation for surgery; treatment of obesity

• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2011
• Volume: 83
• Issue: 4
• Pages: 181-187

Dates

published

1 - 4 - 2011

online

7 - 6 - 2011

Contributors

author

Stanisław Dąbrowiecki

• Department of General and Endocrine Surgery, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń

author

Wojciech Szczęsny

• Department of General and Endocrine Surgery, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń

author

Cezary Popławski

• Department of Gastroenterological Endoscopy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń

author

Dariusz Sosnowski

• Department of General and Endocrine Surgery, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń

References

• Ogden C, Carroll M, Curtin L et al.: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
• Zdrojewski T, Babińska Z, Bandosz P et al.: Association of increased blood preasure with overweight and obesity: estimated from representative surveys in Poland in 1997 and 2002 (NATPOL II, NATPOL III). Med Metabol 2002; 4 (supl.): 32.
• Biela U, Pajk A, Kaczmarek-Chałas K i wsp.: Czstość wystpowania nadwagi i otyłości u kobiet i mżczyzn w wieku 20-74 lata. Wyniki programu WOBASZ. Kard Pol 2005; 63 (supl. 4): 51-54.
• Drenick EJ, Bale GS, Seltzer F et al.: Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243: 443-45.[PubMed][Crossref]
• Meneghini L: Impact of bariatric surgery on type 2 diabetes. Cell Biochem Biophys 2007; 48: 97-102.[WoS]
• Colquitt J, Picot J, Loveman E et al.: Surgery for obesity. Cochrane Database Syst Rev 2009 Apr 15; (2): CD003641.[WoS]
• Strzelczyk J, Szymański D, Nowicki M et al.: Randomized clinical trial of postoperative hernia prophylaxis in open bariatric surgery. Br J Surg 2006; 93: 1347-50.
• Avidor Y, Still C, Brunner M et al.: Primary care and subspecialty management of morbid obesity: referral patterns for bariatric surgery. Surg Obes Relat Dis 2007; 3: 392-407.[Crossref][PubMed]
• Nieben OG, Harboe H.: Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1(8265): 198-99.
• Żurawiński W, Sosada K, Jopek J i wsp.: Endoskopowe leczenie otyłości z zastosowaniem balonu dożołdkowego. Pol Przegl Chir 2010; 82: 754-61.
• Pawlik M, Rydzewska G: Metody terapeutyczne leczenia otyłości z uwzgldnieniem zastosowania balonów dożołdkowych. Pol Merk Lek 2009; 26: 527-31
• Świdnicka-Siergiejko A, Wróblewski E, Dbrowski A: Endoskopowe metody leczenia otyłości. Gastroenterol Praktyczna 2010; 2: 62-72.
• Dumonceau JM: Evidence-based review od bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-17.[WoS][Crossref]
• Dumonceau JM, François E, Hittelet A et al.: Single vs Repeated Treatment with the Intragastric Balloon: A 5-Year Weight Loss Study. Obes Surg 2010; 206: 692-97[WoS]
• Lopez-Nava G, Rubio MA, Prados S et al.: Bio-Enterics® Intragastric Balloon (BIB)®. Single Ambulatory Center Spanish Experience with 714 Consecutive Patients Treated with One or Two Consecutive Balloons. Obes Surg 2010 (w druku).[WoS]
• Angrisani L, Lorenzo M, Borrelli V et al.: Is Bariatric Surgery Necessary after Intragastric Balloon Treatment. Obes Surg 2006; 16: 1135-37.[Crossref][PubMed]
• Vilallonga R, Fort JM, Gonzalez O et al.: Management of patients with hernia or incisional hernia undergoing surgery for morbid obesity. J Obes 2011 (w druku).
• Głowińska-Olszewska B, Urban M: Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 2007; 56: 799-805.[WoS]
• Itani KM, Jensen EH, Finn TS et al.: Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery. Surg Infect (Larchmt) 2008; 9: 131-37.[WoS]
• Lynch RJ, Ranney DN, Shijie C et al.: Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250: 1014-20.[WoS]
• Drapeau CM, D'Aniello C, Brafa A et al.: Surgical site infections in plastic surgery: an Italian multicenter study. J Surg Res 2007; 143: 393-79.
• Mullen JT, Moorman DW, Davenport DL: The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250: 166-72
• Mathur AK, Ghaferi AA, Sell K et al.: Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg 2010; 14: 849-57.[WoS][Crossref][PubMed]
• Nafiu OO, Kheterpal S, Moulding R et al.: The association of body mass index to postoperative outcomes in elderly vascular surgery patients: a reverse J-curve phenomenon. Anesth Analg 2011; 112: 23-29.[WoS][Crossref]
• de Goederen-van der Meij S, Pierik RG, Oudkerk Pool M et al.: Six months of balloon treatment does not predict the success of gastric banding. Obes Surg 2007; 17: 88-94.[Crossref]
• Genco A, Cipriano M, Materia A et al.: Laparoscopic sleeve gastrectomy versus intragastric balloon: a case-control study. Surg Endosc 2009; 23: 1849-53.[Crossref][WoS]
• Milone L, Strong V, Gagner M: Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for superobese patients (BMI≥ 50). Obes Surg 2005; 15: 612-17.[Crossref]
• De Waele B, Reynaert H, Urbain D et al.: Intragastric balloons for preoperative weight reduction. Obes Surg 2000; 10: 58-60.[Crossref][PubMed]
• Fernandes M, Atallah AN, Soares BG et al.: Intragastric balloon for obesity. Cochrane Database Syst Rev 2007 Jan 24; (1): CD004931.[WoS]
• Mathus-Vliegen EM: Intragastric balloon treatment for obesity: what does it really offer? Did Dis 2008; 26: 40-44.[Crossref]
• Crea N, Pata G, Della Casa D et al.: Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg 2009; 19: 1084-88.[Crossref][PubMed][WoS]
• Mui WL, Ng EK, Tsung BY et al.: Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon. Obes Surg 2010; 20: 1128-32.[PubMed][WoS][Crossref]
• Ganesh R, Rao AD, Baladas HG et al.: The Bioenteric® Intragastric Balloon (BIB®) as a treatment for obesity: poor results in Asian patients. Singapore Med J 2007; 48: 227-31[PubMed]
• Cubattoli L, Barneschi C, Mastrocinque E et al.: Cardiac arrest after intragastric balloon insertion in a super-obese patient. Obes Surg 2009; 19: 253-56.[WoS][Crossref]
• Konopko-Zubrzycka M, Baniukiewicz A, Wróblewski E et al.: The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab 2009; 94: 1644-49.[WoS][Crossref]

Identifiers

DOI

10.2478/v10035-011-0028-2